Rapamycin is the gold-standard for longevity interventions
It’s a shame that this idea hasn’t been implemented because the patent is not valid.
This video is a reproduction of a presentation that I gave at the Euro-Geroscience Task Force on \”Challenges in Developing Geroscience Drug Trials\”, held in Toulouse, France, March 23, 2022. This video gives an overview of the current research on rapamycin, a potential drug for longevity and healthspan. It also discusses some of the challenges in clinical development.
Source:
